Exact Mass: 890.2844
Exact Mass Matches: 890.2844
Found 29 metabolites which its exact mass value is equals to given mass value 890.2844,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cycloguanil pamoate
C23H16O6. (C11H14ClN5)2 (890.2822)
P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials > P01BB - Biguanides C471 - Enzyme Inhibitor > C2153 - Dihydrofolate Reductase Inhibitor Same as: D02387
4-{3-[3-(3,5-dihydroxyphenyl)-6-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzofuran-4-yl]-5-{2-[6-hydroxy-3-(3-hydroxyphenyl)-2-phenyl-2,3-dihydro-1-benzofuran-4-yl]ethenyl}-2,3-dihydro-1-benzofuran-2-yl}benzene-1,2-diol
4-{3-[3-(3,5-dihydroxyphenyl)-6-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzofuran-4-yl]-5-{2-[6-hydroxy-3-(3-hydroxyphenyl)-2-phenyl-2,3-dihydro-1-benzofuran-4-yl]ethenyl}-2,3-dihydro-1-benzofuran-2-yl}benzene-1,2-diol is classified as a member of the 2-arylbenzofuran flavonoids. 2-arylbenzofuran flavonoids are phenylpropanoids containing the 2-phenylbenzofuran moiety. 4-{3-[3-(3,5-dihydroxyphenyl)-6-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzofuran-4-yl]-5-{2-[6-hydroxy-3-(3-hydroxyphenyl)-2-phenyl-2,3-dihydro-1-benzofuran-4-yl]ethenyl}-2,3-dihydro-1-benzofuran-2-yl}benzene-1,2-diol is considered to be a practically insoluble (in water) and a very weak acidic compound. 4-{3-[3-(3,5-dihydroxyphenyl)-6-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzofuran-4-yl]-5-{2-[6-hydroxy-3-(3-hydroxyphenyl)-2-phenyl-2,3-dihydro-1-benzofuran-4-yl]ethenyl}-2,3-dihydro-1-benzofuran-2-yl}benzene-1,2-diol can be found in humans.
cyanidin 3-O-[2-O-(beta-D-xylopyranosyl)-6-O-(cis-p-coumaroyl)-beta-D-glucopyranoside]-5-O-[beta-D-glucopyranoside]
Acanthoside B
Acanthoside B is a bioactive metabolite belonging to the class of lignans, which are a group of phytoestrogens found in plants. This compound has garnered attention for its various pharmacological properties and potential therapeutic applications. (+)-syringaresinol beta-D-glucoside is a beta-D-glucoside. It has a role as a metabolite. It is functionally related to a (+)-syringaresinol. Chemical Structure: Acanthoside B has the chemical formula C28H36O13. It is derived from syringaresinol, a lignan, and is specifically a glucoside of this compound. The structure of Acanthoside B includes a glucose moiety attached to the lignan core, which influences its solubility and bioavailability. Source: Acanthoside B is naturally occurring and can be extracted from various plant species, including Acanthus ilicifolius and Ligustrum obtusifolium. It is one of the many bioactive compounds found in these plants, which are known for their medicinal properties. Pharmacological Properties: Anti-inflammatory Effects: Acanthoside B has been shown to possess anti-inflammatory properties, which could be beneficial in the treatment of inflammatory diseases. Neuroprotective Effects: Research suggests that Acanthoside B may have neuroprotective effects, including the ability to alleviate cognitive impairments and protect against neurodegenerative diseases such as Alzheimer's disease. It is believed to work by restoring cholinergic activity, reducing oxidative stress, and inhibiting neuroinflammation. Antiamnesic Activity: Acanthoside B has demonstrated antiamnesic effects, meaning it can help prevent or reduce memory loss. This makes it a potential candidate for the treatment of conditions involving memory impairment. Other Activities: Additionally, Acanthoside B may have other biological activities, such as antioxidant and anti-cancer properties, although these areas require further research. Mechanism of Action: The exact mechanisms by which Acanthoside B exerts its effects are still under investigation. However, it is known to interact with various biological pathways, including the activation of the TrkB/CREB/BDNF pathway, which is involved in neuroprotection and cognitive function. Applications: Due to its diverse pharmacological profile, Acanthoside B is of interest for pharmaceutical research and development. It could potentially be developed into a therapeutic agent for the treatment of inflammatory diseases, neurodegenerative disorders, and other conditions where its properties could be beneficial. Safety and Toxicity: As with any bioactive compound, the safety and toxicity of Acanthoside B need to be thoroughly evaluated before it can be used in clinical settings. Current research is focused on understanding its pharmacokinetics, bioavailability, and potential side effects. Research and Future Directions: Ongoing research is aimed at further elucidating the biological activities of Acanthoside B, understanding its mechanisms of action at the molecular level, and exploring its potential for clinical applications. Preclinical studies and clinical trials will be essential to determine its efficacy and safety in humans. Acanthoside B is a promising natural compound with a range of bioactive properties that make it a valuable subject for scientific research and a potential candidate for therapeutic development.
Beta-Methoxy-Asn-Albicidin
4-{3-[3-(3,5-dihydroxyphenyl)-6-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzofuran-4-yl]-5-{2-[6-hydroxy-3-(3-hydroxyphenyl)-2-phenyl-2,3-dihydro-1-benzofuran-4-yl]ethenyl}-2,3-dihydro-1-benzofuran-2-yl}benzene-1,2-diol
Cycloguanil pamoate
P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials > P01BB - Biguanides C471 - Enzyme Inhibitor > C2153 - Dihydrofolate Reductase Inhibitor
alpha-D-GlcpNAc-(1->2)-6-PEA-L-alpha-D-Hepp-(1->3)-[beta-D-Glcp-(1->4)]-L-alpha-D-Hepp
alpha-D-GlcpNAc-(1->2)-3-PEA-L-alpha-D-Hepp-(1->3)-[beta-D-Glcp-(1->4)]-L-alpha-D-Hepp
5-{6-hydroxy-4-[(E)-2-{3-[6-hydroxy-3-(3-hydroxyphenyl)-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzofuran-4-yl]-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzofuran-5-yl}ethenyl]-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzofuran-3-yl}benzene-1,3-diol
3-[(4R,6Z,13S,14S,18S,19S)-4,8,13-tris(2-carboxyethyl)-3,9,14-tris(carboxymethyl)-4,14,19,23-tetramethyl-21-oxo-22-oxa-24,25,26,27-tetrazahexacyclo[15.6.1.12,5.17,10.112,15.01,19]heptacosa-2,5(27),6,8,10,12(25),15,17(24)-octaen-18-yl]propanoic acid
(2s,3r,4s,5r,6r)-3,5-dihydroxy-2-{[(1s,2s,4s,5s,6s,10s)-5-hydroxy-2-({[(2e)-3-phenylprop-2-enoyl]oxy}methyl)-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-10-yl]oxy}-6-(hydroxymethyl)oxan-4-yl (1s,4as)-7-[(acetyloxy)methyl]-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h-cyclopenta[c]pyran-4-carboxylate
4,5-dihydroxy-2-{[5-hydroxy-2-({[(2e)-3-phenylprop-2-enoyl]oxy}methyl)-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-10-yl]oxy}-6-(hydroxymethyl)oxan-3-yl 7-[(acetyloxy)methyl]-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h-cyclopenta[c]pyran-4-carboxylate
(2s,3s,9s,17s)-3-[(2s,3s)-3-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzofuran-4-yl]-2,9,17-tris(4-hydroxyphenyl)-8-oxapentacyclo[8.7.2.0⁴,¹⁸.0⁷,¹⁹.0¹¹,¹⁶]nonadeca-4,6,11,13,15,18-hexaene-5,13,15-triol
2-(2-chloro-4-{7-[(2-chloro-1h-indol-3-yl)methyl]-6,12-dihydroxy-3-methoxy-8,10,13,15,17,18-hexamethyl-2,9-dioxo-1-oxa-5,8,11-triazacyclooctadeca-5,11,15-trien-4-yl}phenoxy)-4,5,6-trihydroxyoxane-3-carboxylic acid
2-{2-chloro-4-[(3s,7r,10s,13s,15z,17s,18r)-7-[(2-chloro-1h-indol-3-yl)methyl]-6,12-dihydroxy-3-methoxy-8,10,13,15,17,18-hexamethyl-2,9-dioxo-1-oxa-5,8,11-triazacyclooctadeca-5,11,15-trien-4-yl]phenoxy}-4,5,6-trihydroxyoxane-3-carboxylic acid
4,5-dihydroxy-2-[(5-hydroxy-2-{[(3-phenylprop-2-enoyl)oxy]methyl}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-10-yl)oxy]-6-(hydroxymethyl)oxan-3-yl 7-[(acetyloxy)methyl]-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h-cyclopenta[c]pyran-4-carboxylate
(2s,3r,4s,5s,6r)-4,5-dihydroxy-2-{[(1r,2s,4s,5s,6s,10s)-5-hydroxy-2-({[(2e)-3-phenylprop-2-enoyl]oxy}methyl)-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-10-yl]oxy}-6-(hydroxymethyl)oxan-3-yl (1s,4as)-7-[(acetyloxy)methyl]-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h-cyclopenta[c]pyran-4-carboxylate
(2s,3s,9s,17r)-3-[(2s,3s)-3-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzofuran-4-yl]-2,9,17-tris(4-hydroxyphenyl)-8-oxapentacyclo[8.7.2.0⁴,¹⁸.0⁷,¹⁹.0¹¹,¹⁶]nonadeca-4,6,11,13,15,18-hexaene-5,13,15-triol
LPIP3(22:3)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
PIP3(O-22:3)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
PIP3(P-15:2_7:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
